Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
15.92
-10.92
-68.59%
Share Warrants & Outstandings
Total Reserve
1.97
82.90
-80.93
-97.62%
Shareholder's Funds
6.97
98.82
-91.85
-92.95%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.62
31.40
-28.78
-91.66%
Secured Loans
1.51
31.40
-29.89
-95.19%
Unsecured Loans
1.11
0.00
1.11
0.00%
Deferred Tax Assets / Liabilities
-0.07
-0.40
0.33
82.50%
Other Long Term Liabilities
0.25
1.28
-1.03
-80.47%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
5.60
-5.60
-100.00%
Total Non-Current Liabilities
2.80
37.89
-35.09
-92.61%
Current Liabilities
Trade Payables
1.31
81.85
-80.54
-98.40%
Other Current Liabilities
3.04
17.24
-14.20
-82.37%
Short Term Borrowings
7.74
113.21
-105.47
-93.16%
Short Term Provisions
0.00
1.16
-1.16
-100.00%
Total Current Liabilities
12.08
213.46
-201.38
-94.34%
Total Liabilities
21.85
350.17
-328.32
-93.76%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.86
156.94
-155.08
-98.81%
Less: Accumulated Depreciation
0.87
70.17
-69.30
-98.76%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.99
86.77
-85.78
-98.86%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.79
-2.79
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
2.16
-2.16
-100.00%
Long Term Loans & Advances
0.00
6.23
-6.23
-100.00%
Other Non Current Assets
1.12
4.57
-3.45
-75.49%
Total Non-Current Assets
2.11
102.52
-100.41
-97.94%
Current Assets Loans & Advances
Current Investments
0.00
2.47
-2.47
-100.00%
Inventories
7.06
102.78
-95.72
-93.13%
Sundry Debtors
5.64
94.85
-89.21
-94.05%
Cash and Bank
5.21
7.94
-2.73
-34.38%
Other Current Assets
0.00
6.97
-6.97
-100.00%
Short Term Loans and Advances
1.82
32.65
-30.83
-94.43%
Total Current Assets
19.74
247.65
-227.91
-92.03%
Net Current Assets (Including Current Investments)
7.65
34.19
-26.54
-77.63%
Total Current Assets Excluding Current Investments
19.74
245.18
-225.44
-91.95%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
21.85
350.17
-328.32
-93.76%
Contingent Liabilities
0.00
17.10
-17.10
-100.00%
Total Debt
10.36
144.61
-134.25
-92.84%
Book Value per share (adjusted)
13.93
62.07
-48.14
-77.56%
Annual - Borrowings
Borrowings 10.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 19.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024






